Aardvark Therapeutics AARD Balance Sheet (2024-2026)

NASDAQ AARD
$5.89 -0.86 (-12.74%)
At close: Aug 20, 2026 · 4:00 PM EDT
Balance Sheet Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter) 61.64M151.30M141.80M126.40M47.05M91.20M73.90M
Short-term Investments (Quarter) 12.02M124.76M115.82M87.06M62.98M28.76M0.02M
Cash & Current Investments (Quarter) 73.66M276.06M257.62M213.47M110.03M119.96M73.92M
Receivables (Quarter) 1.40M1.40M1.40M
Prepaid Assets (Quarter) 0.47M3.29M2.95M2.86M1.86M2.38M6.79M
Current Assets (Quarter) 74.14M154.55M144.77M129.21M111.89M93.58M80.66M
Non-Current Assets
Other Non-Current Assets (Quarter) 2.63M1.84M2.19M3.58M4.94M4.74M0.17M
Non-Current Assets (Quarter) 3.37M2.47M2.71M4.02M5.29M5.01M0.80M
Assets (Quarter) 77.51M157.03M147.47M133.23M117.18M98.59M81.46M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 2.30M2.56M5.06M4.44M2.07M4.49M2.09M
Payables (Quarter) 2.30M2.56M5.06M4.44M2.07M4.49M2.09M
Accumulated Expenses (Quarter) 0.23M3.03M4.84M2.15M8.04M6.78M3.90M
Other Accumulated Expenses (Quarter) 0.17M0.64M0.31M0.32M0.42M0.76M0.54M
Current Leases (Quarter) 0.34M0.39M0.42M0.43M0.44M0.34M0.40M
Total Current Liabilities (Quarter) 4.93M5.98M10.31M10.74M10.55M11.60M6.39M
Non-Current Liabilities
Preferred Stock Liabilities (Quarter) 43.90M126.84M126.76M126.76M
Operating Leases (Quarter) 0.44M0.34M0.23M0.12M0.28M
Other Non-Current Liabilities (Quarter) 0.03M0.02M0.01M
Total Non-Current Liabilities (Quarter) 5.37M6.31M10.54M10.85M10.55M
Total Liabilities (Quarter) 5.39M6.34M10.55M10.85M10.55M11.60M6.66M
Shareholder's Equity
Common Equity (Quarter) -36.91M-42.31M-46.17M-54.64M150.69M136.93M122.38M106.63M86.99M74.80M
Liabilities and Shareholders Equity (Quarter) 77.51M157.03M147.47M133.23M117.18M98.59M81.46M
Retained Earnings (Quarter) 0.04M-0.00M0.08M0.08M-137.51M-151.90M
Treasury Shares (Quarter) 48.91M96.94M96.94M96.94M